ONE WAY LIVER GENOMICS
OWL is a biotechnology company leader in the field of Metabolomics, with diagnostics products and unique R&D services.
Launch date
Employees
Market cap
-
Enterprise valuation
€4—6m (Dealroom.co estimates Jun 2020.)
Company register number B83390443
Mungia Basque Country (HQ)
Financials
Estimates*
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | <1m | <1m | 1.1m | 1.6m | 1.9m | 1.7m | 1.2m |
| % growth | (22 %) | 16 % | 50 % | 46 % | 22 % | (9 %) | - |
| EBITDA | (<1m) | (<1m) | <1m | <1m | 1.4m | (<1m) | - |
| % EBITDA margin | (25 %) | (25 %) | 22 % | 25 % | 72 % | (24 %) | - |
| Profit | (1.3m) | (1.2m) | (<1m) | (<1m) | <1m | (5.0m) | - |
| % profit margin | (216 %) | (173 %) | (75 %) | (38 %) | 16 % | (288 %) | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Spinout | ||
€10.0k | Grant | ||
N/A | Support Program | ||
€19.2k | Grant | ||
€35.2k | Grant | ||
€21.4k | Grant | ||
€20.7k | Grant | ||
€15.7k | Grant | ||
€15.5k | Grant | ||
N/A | Grant | ||
€21.3k | Grant | ||
€91.4k | Grant | ||
€1.0m | Seed | ||
| Total Funding | €1.3m | ||
Related Content
Recent News about ONE WAY LIVER GENOMICS
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.